Mylan announced it has received final approval from the FDA for its Abbreviated New Drug Applications (ANDA) for Rizatriptan Benzoate Tablets and Rizatriptan Benzoate Orally Disintegrating Tablets ...
Rizatriptan (as benzoate) 10mg; orally-disintegrating tabs; peppermint flavor; contains phenylalanine. Maxalt-MLT Orally Disintegrating Tablets, 10 mg, are white to off-white, round lyophilized orally ...
PITTSBURGH — Mylan announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug applications for ...
July 7, 2010 (Los Angeles, California) — Patients with migraine who have not experienced relief with sumatriptan may benefit from another 5-hydroxytryptamine receptor agonist, report researchers ...
Par Pharmaceutical Companies, Inc., a privately held, US-based specialty pharmaceutical company, has announced that its operating subsidiary, Par Pharmaceutical, Inc. begun shipping 5 mg and 10 mg ...
SAINT LAURENT, Quebec, May 29, 2012--IntelGenx Corp. ("IntelGenx") today announced the completion of the pivotal bioequivalence study for a novel oral thin-film formulation of Rizatriptan, the active ...
A net positive change was seen for fluoxetine starts and rizatriptan ODT use, and a net negative change was seen for COX-2 inhibitor use. Fluoxetine starts increased by 2.0%, rizatriptan use increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results